Soluble cytokine receptors are present in normal human urine

doi:10.1084/jem.170.4.1409

This Article

	Full Text (PDF, 356K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Novick, D.
	Articles by Rubinstein, M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Novick, D.
	Articles by Rubinstein, M.


Social Bookmarking

	What's this?

ARTICLES

Soluble cytokine receptors are present in normal human urine

D Novick, H Engelmann, D Wallach and M Rubinstein
Department of Virology, Weizmann Institute of Science, Rehovot, Israel.

Affinity chromatography of crude human urinary proteins on either human rIL-6, human rIFN-gamma, or anti-IFN-gamma-R mAb yielded the two respective soluble receptors in significant quantities. A single sequence of 30 amino acid residues was obtained by NH2-terminal microsequencing of the protein peak purified in tandem by affinity chromatography on an IL-6 column and reversed-phase HPLC. This sequence was identical to the predicted NH2-terminal sequence of IL-6-R as previously reported. Analysis of the eluted proteins from both IFN- gamma and anti-IFN-gamma-R columns by inhibition of solid phase RIA, ELISA, SDS-PAGE, and Western blotting proved the existence of soluble IFN-gamma-R in normal urine. Our finding, together with the already known presence of urinary TNF binding proteins and a soluble IL-2-R both in plasma and in urine, indicates that release of soluble cytokine receptors into body fluids is a general phenomenon that occurs under normal physiological conditions.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Adam, N., Rabe, B., Suthaus, J., Grotzinger, J., Rose-John, S., Scheller, J. (2009). Unraveling Viral Interleukin-6 Binding to gp130 and Activation of STAT-Signaling Pathways Independently of the Interleukin-6 Receptor. J. Virol. 83: 5117-5126 [Abstract] [Full Text]
Walker, F., Zhang, H.-H., Matthews, V., Weinstock, J., Nice, E. C., Ernst, M., Rose-John, S., Burgess, A. W. (2008). IL6/sIL6R complex contributes to emergency granulopoietic responses in G-CSF- and GM-CSF-deficient mice. Blood 111: 3978-3985 [Abstract] [Full Text]
Paland, N., Bohme, L., Gurumurthy, R. K., Maurer, A., Szczepek, A. J., Rudel, T. (2008). Reduced Display of Tumor Necrosis Factor Receptor I at the Host Cell Surface Supports Infection with Chlamydia trachomatis. J. Biol. Chem. 283: 6438-6448 [Abstract] [Full Text]
Lebbink, R. J., van den Berg, M. C. W., de Ruiter, T., Raynal, N., van Roon, J. A. G., Lenting, P. J., Jin, B., Meyaard, L. (2008). The Soluble Leukocyte-Associated Ig-Like Receptor (LAIR)-2 Antagonizes the Collagen/LAIR-1 Inhibitory Immune Interaction. J. Immunol. 180: 1662-1669 [Abstract] [Full Text]
Chadha, K., Weinstock-Guttman, B., Zivadinov, R., Bhasi, K., Muhitch, J., Feichter, J., Tamano-Blanco, M., Abdelrahman, N., Ambrus, J. Sr, Munschauer, F., Ramanathan, M. (2006). Interferon Inhibitory Activity in Patients With Multiple Sclerosis. Arch Neurol 63: 1579-1584 [Abstract] [Full Text]
Kovaleva, M., Bussmeyer, I., Rabe, B., Grotzinger, J., Sudarman, E., Eichler, J., Conrad, U., Rose-John, S., Scheller, J. (2006). Abrogation of Viral Interleukin-6 (vIL-6)-Induced Signaling by Intracellular Retention and Neutralization of vIL-6 with an Anti-vIL-6 Single-Chain Antibody Selected by Phage Display.. J. Virol. 80: 8510-8520 [Abstract] [Full Text]
Novick, D., Rubinstein, M., Azam, T., Rabinkov, A., Dinarello, C. A., Kim, S.-H. (2006). Proteinase 3 is an IL-32 binding protein. Proc. Natl. Acad. Sci. USA 103: 3316-3321 [Abstract] [Full Text]
Dimitriadis, E., White, C.A., Jones, R.L., Salamonsen, L.A. (2005). Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update 11: 613-630 [Abstract] [Full Text]
Obreja, O., Biasio, W., Andratsch, M., Lips, K. S., Rathee, P. K., Ludwig, A., Rose-John, S., Kress, M. (2005). Fast modulation of heat-activated ionic current by proinflammatory interleukin 6 in rat sensory neurons. Brain 128: 1634-1641 [Abstract] [Full Text]
McLoughlin, R. M., Hurst, S. M., Nowell, M. A., Harris, D. A., Horiuchi, S., Morgan, L. W., Wilkinson, T. S., Yamamoto, N., Topley, N., Jones, S. A. (2004). Differential Regulation of Neutrophil-Activating Chemokines by IL-6 and Its Soluble Receptor Isoforms. J. Immunol. 172: 5676-5683 [Abstract] [Full Text]
Chadha, K. C., Ambrus, J. L. Jr., Dembinski, W., Ambrus, J. L. Sr. (2004). Interferons and Interferon Inhibitory Activity in Disease and Therapy. Exp. Biol. Med. 229: 285-290 [Abstract] [Full Text]
Legendre, F., Dudhia, J., Pujol, J.-P., Bogdanowicz, P. (2003). JAK/STAT but Not ERK1/ERK2 Pathway Mediates Interleukin (IL)-6/Soluble IL-6R Down-regulation of Type II Collagen, Aggrecan Core, and Link Protein Transcription in Articular Chondrocytes. ASSOCIATION WITH A DOWN-REGULATION OF SOX9 EXPRESSION. J. Biol. Chem. 278: 2903-2912 [Abstract] [Full Text]
Hayashi, M., Rho, M.-C., Fukami, A., Enomoto, A., Nonaka, S., Sekiguchi, Y., Yanagisawa, T., Yamashita, A., Nogawa, T., Kamano, Y., Komiyama, K. (2002). Biological Activity of a Novel Nonpeptide Antagonist to the Interleukin-6 Receptor 20S,21-Epoxy-resibufogenin-3-formate. J. Pharmacol. Exp. Ther. 303: 104-109 [Abstract] [Full Text]
Coyne, C.P., Howell, T., Smodlaka, H., Willetto, C., Fenwick, B. W., Chenney, E. (2002). Alterations in membrane-associated CD14 expression and the simultaneous liberation of soluble CD14 fragment in adherent macrophages mediated by a leukocyte carboxyl/aspartate protease. Innate Immunity 8: 273-283 [Abstract]
Dinarello, C A (2001). Novel targets for interleukin 18 binding protein. Ann Rheum Dis 60: iii18-24 [Abstract] [Full Text]
JONES, S. A., HORIUCHI, S., TOPLEY, N., YAMAMOTO, N., FULLER, G. M. (2001). The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 15: 43-58 [Abstract] [Full Text]
Mohamed-Ali, V., Goodrick, S., Bulmer, K., Holly, J. M. P., Yudkin, J. S., Coppack, S. W. (1999). Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am. J. Physiol. Endocrinol. Metab. 277: E971-E975 [Abstract] [Full Text]
Cole, A. R., Hall, N. E., Treutlein, H. R., Eddes, J. S., Reid, G. E., Moritz, R. L., Simpson, R. J. (1999). Disulfide Bond Structure and N-Glycosylation Sites of the Extracellular Domain of the Human Interleukin-6 Receptor. J. Biol. Chem. 274: 7207-7215 [Abstract] [Full Text]
Balcewicz-Sablinska, M. K., Keane, J., Kornfeld, H., Remold, H. G. (1998). Pathogenic Mycobacterium tuberculosis Evades Apoptosis of Host Macrophages by Release of TNF-R2, Resulting in Inactivation of TNF-{alpha}. J. Immunol. 161: 2636-2641 [Abstract] [Full Text]
Silacci, P., Dayer, J.-M., Desgeorges, A., Peter, R., Manueddu, C., Guerne, P.-A. (1998). Interleukin (IL)-6 and Its Soluble Receptor Induce TIMP-1 Expression in Synoviocytes and Chondrocytes, and Block IL-1-induced Collagenolytic Activity. J. Biol. Chem. 273: 13625-13629 [Abstract] [Full Text]
Zhang, J.-G., Zhang, Y., Owczarek, C. M., Ward, L. D., Moritz, R. L., Simpson, R. J., Yasukawa, K., Nicola, N. A. (1998). Identification and Characterization of Two Distinct Truncated Forms of gp130 and a Soluble Form of Leukemia Inhibitory Factor Receptor alpha -Chain in Normal Human Urine and Plasma. J. Biol. Chem. 273: 10798-10805 [Abstract] [Full Text]
Curtis, D. J., Hilton, D. J., Roberts, B., Murray, L., Nicola, N., Begley, C. G. (1997). Recombinant Soluble Interleukin-11 (IL-11) Receptor alpha -Chain Can Act as an IL-11 Antagonist. Blood 90: 4403-4412 [Abstract] [Full Text]
Reed, M. J., Purohit, A. (1997). Breast Cancer and the Role of Cytokines in Regulating Estrogen Synthesis: An Emerging Hypothesis. Endocr. Rev. 18: 701-715 [Abstract] [Full Text]
Peters, M., Schirmacher, P., Goldschmitt, J., Odenthal, M., Peschel, C., Fattori, E., Ciliberto, G., Dienes, H.-P., Buschenfelde, K.-H. M. z., Rose-John, S. (1997). Extramedullary Expansion of Hematopoietic Progenitor Cells in Interleukin (IL)-6-sIL-6R Double Transgenic Mice. JEM 185: 755-766 [Abstract] [Full Text]
Mossman, K., Upton, C., McFadden, G. (1995). The Myxoma Virus-soluble Interferon-[IMAGE] Receptor Homolog, M-T7, Inhibits Interferon-[IMAGE] in a Species-specific Manner. J. Biol. Chem. 270: 3031-3038 [Abstract] [Full Text]
Fischer, D., Tal, N, Novick, D, Barak, S, Rubinstein, M (1993). An antiviral soluble form of the LDL receptor induced by interferon. Science 262: 250-253 [Abstract]
Davis, S, Aldrich, T., Ip, N., Stahl, N, Scherer, S, Farruggella, T, DiStefano, P., Curtis, R, Panayotatos, N, Gascan, H, et, al. (1993). Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses. Science 259: 1736-1739 [Abstract]
Upton, C, Mossman, K, McFadden, G (1992). Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 258: 1369-1372 [Abstract]